The Edison Awards, a global platform celebrating game-changing innovations, took center stage last night to honor the winners of the 2025 Edison Awards. This year's recipients exemplify ingenuity, ...

Summit Therapeutics' ivonescimab outperforms Keytruda in Phase 3 lung cancer trials. Crucial Western market approval depends ...

Jeffrey Graves; President, Chief Executive Officer, Director; 3D Systems Corp Jeffrey Creech; Chief Financial Officer, Executive Vice President; 3D Systems Corp Greetings, and welcome to the 3D ...

including non-small cell lung cancer (NSCLC), with potential applications in other solid tumors. Black Diamond Therapeutics will receive an upfront payment of $70 million and will be eligible to ...

Merck signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion.

Good day, everyone, and welcome to today's Arcturus Therapeutics Fourth Quarter and ... with CSL to prepare KOSTAIVE registration for the United States and the United Kingdom.The KOSTAIVE US ...

including non-small cell lung cancer (NSCLC), with potential applications in other solid tumors. Black Diamond Therapeutics will receive an upfront payment of $70 million and will be eligible to ...

Market Cap: $8.9 billion With a unique business model combining ... hypertension, United Therapeutics (NASDAQ:UTHR) develops ...

Announced demonstrated ability to deliver transient gene therapy (payload) to tumors using systemic antitumor virotherapy platformFiled IND in ...